D.E. Shaw & Co

D.E. Shaw & Co’s aTyr Pharma ATYR Stock Holding History

D.E. Shaw & Co’s Portfolio ATYR Stock Details ATYR Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$60.1K	Buy
2025 Q2	$77.5K	Buy
2022 Q2	–	Sell
2022 Q1	$101K	Buy
2016 Q1	–	Sell
2015 Q4	$145K	Buy